8-K: Cardlytics Amends CEO Compensation, Grants 1.2 Million Equity Awards Amidst Revised Severance Terms

Cardlytics, Inc. has updated CEO Amit Gupta's compensation package, granting 1.2 million equity awards and enhancing severance benefits, as detailed in a recent SEC filing.

Summary

• Cardlytics, Inc. (CDLX) entered into an amended and restated offer letter and severance agreement with CEO Amit Gupta on June 23, 2025.
• The amended offer letter grants Mr. Gupta 1,000,000 Restricted Stock Units (RSUs) and 200,000 Performance Stock Units (PSUs), totaling 1,200,000 shares, as part of the 'Second Tranche Awards'.
• This grant of 1,200,000 shares for a value of $5,000,000 exceeds the previously announced maximum of 1,000,000 shares for the same value.
• The Second Tranche 2025 RSUs will vest 50% on June 23, 2026, and the remaining 50% in equal quarterly amounts thereafter, subject to continuous service.
• The Second Tranche 2025 PSUs will vest based on specified share price targets over a three-year performance period starting April 1, 2025, with no vesting prior to April 1, 2026.
• Mr. Gupta is required to repay the pre-tax value of vested Second Tranche 2025 RSUs if he terminates employment before August 16, 2025.
• The company also agreed to grant Mr. Gupta additional RSUs and/or PSUs (the '2026 RSUs') with a value of $5,000,000, up to 1,200,000 shares, on or before May 31, 2026.
• The amended severance agreement provides Mr. Gupta with a separation payment equal to 18 months of his base salary and 18 months of continued medical benefits if terminated without Cause or if he resigns for Good Reason.
• Under the amended severance agreement, all outstanding and unvested equity awards will immediately fully vest upon termination without Cause or resignation for Good Reason within three months before or one year following a Change in Control.

Sentiment

Score: 4

Explanation: The sentiment is slightly negative for shareholders due to the increased share count for the same compensation value, implying greater dilution. However, it is positive for executive retention and aligns a portion of compensation with performance targets. The document is purely factual reporting of compensation changes.

Positives

• Enhanced compensation and severance package for CEO Amit Gupta may aid in executive retention and alignment with long-term company performance.
• The structure of PSUs ties a portion of the CEO's compensation directly to share price performance targets, aligning executive incentives with shareholder value creation.

Negatives

• The grant of 1,200,000 shares for the 'Second Tranche Awards' for a value of $5,000,000 implies a lower share price at the time of grant compared to the previous maximum of 1,000,000 shares for the same value, indicating increased dilution for existing shareholders.
• The enhanced severance benefits, particularly the immediate full vesting of unvested equity upon a change in control, could be viewed as a 'golden parachute' arrangement.

Risks

• Potential shareholder dilution due to the increased number of shares granted for the same compensation value.
• Risk of executive departure before August 16, 2025, which would trigger a repayment clause for vested RSUs, indicating a short-term retention concern.

Future Outlook

The document outlines future equity grants to the CEO, specifically the '2026 RSUs' with a value of $5,000,000, to be granted on or before May 31, 2026, subject to Board or Compensation Committee approval. The vesting of PSUs is tied to future share price targets over a three-year performance period commencing April 1, 2025.

Industry Context

This filing is specific to executive compensation and does not provide broader industry context. However, executive compensation structures, particularly those involving significant equity grants and change-in-control provisions, are common across publicly traded companies in the technology and financial services sectors, aiming to align executive incentives with shareholder interests and ensure leadership stability.

Corporate Governance

Stakeholder Impact

• **Shareholders:** Potential for increased dilution due to the grant of 1,200,000 shares for the 'Second Tranche Awards' for the same $5,000,000 value, which is higher than the previously stated maximum of 1,000,000 shares. The enhanced severance benefits could also be a concern.
• **Employees:** No direct impact mentioned, but changes to CEO compensation can sometimes set precedents or influence overall compensation philosophy.
• **Management (CEO Amit Gupta):** Significantly enhanced compensation package, including substantial equity awards and improved severance terms, providing greater financial incentives and security.

Next Steps

• The Company intends to file the Amended and Restated Offer Letter and Severance Agreement as exhibits to its Quarterly Report on Form 10-Q for the quarter ending June 30, 2025.
• The Board of Directors or Compensation Committee is expected to determine the terms and approve the grant of the '2026 RSUs' to Mr. Gupta on or before May 31, 2026.

Key Dates

Keywords

Cardlytics, CDLX, SEC filing, 8-K, CEO compensation, equity awards, restricted stock units, performance stock units, severance agreement, executive compensation, corporate governance, dilution, Amit Gupta